文献速递皮肤肿瘤

丝聚蛋白基因功能缺失突变与恶性黑色素瘤的病例对照研究

Loss-of-function mutations in filaggrin gene and malignant melanoma: a case-control study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-09-12

该研究比较867例恶性黑色素瘤活检样本与9965例普通人群对照的FLG突变频率。黑色素瘤组纯合突变携带者2例(0.23%)、杂合突变携带者80例(9.4%),对照组分别为18例(0.18%)和835例(8.4%),组间比较P值均无统计学意义。结论提示FLG突变与恶性黑色素瘤发生无关。

要点

  • FLG突变状态与恶性黑色素瘤发生无显著关联
  • 表皮丝聚蛋白及其降解产物缺乏不影响黑色素瘤风险
  • 病例对照设计未发现FLG突变对黑色素瘤的易感性影响

核心结论

  • 在所研究人群中,FLG突变与恶性黑色素瘤无关。
  • 表皮丝聚蛋白及其降解产物缺乏不显著影响恶性黑色素瘤风险。

研究设计与样本

  • 病例对照研究,比较恶性黑色素瘤活检样本与普通人群队列的FLG突变频率。
  • 共纳入867例恶性黑色素瘤活检和9965例普通人群对照,均进行FLG基因分型。
  • 采用Pearson卡方检验和Fisher精确检验比较两组。

主要发现

  • 黑色素瘤组纯合突变携带者2例(0.23%),杂合突变携带者80例(9.4%)。
  • 普通人群对照组纯合突变携带者18例(0.18%),杂合突变携带者835例(8.4%)。
  • 两组比较的Fisher精确检验和Pearson卡方检验P值均无统计学意义。

临床怎么用

  • FLG突变状态暂不作为恶性黑色素瘤风险分层的依据。
  • 对于FLG突变携带者,无需因该突变额外增加黑色素瘤筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Loss-of-function mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its degradation products, urocanic acid, which may be protective against ultraviolet irradiation. OBJECTIVE: We aimed to investigate the association between FLG mutation status and the occurrence of malignant melanoma (MM) in Danish adults. METHODS: The prevalence of FLG mutations in a sample of MM biopsies was compared with a FLG-genotyped cohort from two general population studies. Pearson's chi-squared and Fisher's exact tests were used to compare the two groups. RESULTS: A total of 867 MM biopsies and 9965 general population controls were genotyped, respectively. In the MM sample, two (0.23%) individuals were homozygous and 80 (9.4%) were heterozygous mutation carriers. In the general population controls, the prevalence of FLG mutations was 18 (0.18%) and 835 (8.4%) for homozygous and heterozygous mutations, respectively. Fisher's exact test and Pearson's chi-squared test yielded non-significant P-values when the groups were compared. CONCLUSION: FLG mutation was not associated with MM in the studied populations. This finding indicates that epidermal deficiency of filaggrin and its degradation products does not influence the risk of MM significantly.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Thyssen JP, Andersen YMF, Balslev E, et al. Loss-of-function mutations in filaggrin gene and malignant melanoma: a case-control study. J Eur Acad Dermatol Venereol. 2017. PMID: 28833578. doi:10.1111/jdv.14532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。